LEONID METELITSA to Receptors, Antigen
This is a "connection" page, showing publications LEONID METELITSA has written about Receptors, Antigen.
Connection Strength
0.621
-
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33.
Score: 0.484
-
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. J Clin Invest. 2016 06 01; 126(6):2341-55.
Score: 0.137